Alpha DNA Investment Management’s AT&T T Stock Holding History

Alpha DNA Investment Management’s Portfolio T Stock Details T Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-4,089	Closed	-$93K	–	584
2021 Q1	$93K	Buy	4,089 +416	+11%	+$9.2K	0.11%	122
2020 Q4	$79K	Buy	+3,673	New	+$79.2K	0.08%	142

Other funds holding T

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Newport Trust Company Washington, District of Columbia $40.7B AUM 24.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Alpha DNA Investment Management's T Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of AT&T (T) in Q2 2021, closing a stake of 4,089 shares — an estimated $93K sold.

Alpha DNA Investment Management first reported a position in T in Q4 2020 and held it in 2 quarters. The position peaked at $93K in Q1 2021. 2,562 funds tracked by Wall St. Rank hold T as of Q2 2021.

Alpha DNA Investment Management reported no remaining AT&T position as of Q2 2021 after selling out during the quarter.
Alpha DNA Investment Management sold 4,089 AT&T shares in Q2 2021, an estimated $93K.
Alpha DNA Investment Management first reported a position in AT&T in Q4 2020 and held it in 2 quarters.
Alpha DNA Investment Management's AT&T position peaked at $93K in Q1 2021.
2,562 funds tracked by Wall St. Rank held AT&T as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.